Invitrogen Corporation v. General Electric Company et al, No. 6:08-cv-00112 (E.D. Tex. Feb. 9, 2009)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Before the Court is Defe ndants General Electric Company d.b.a. GE H ealthcare and GE Healthcare Bio-Sciences Corp.’s (c ollectively “GE”) Motion to Transfe r Venue, (Doc. No. 30) , Reply in Support, (Doc. No. 42), and Plaintiff Invitrogen Corp.’s (“Invitrogen”) Response, (Doc. No. 39). For the reasons stated below, Defendant’s Motion is GRANTED. BACKGROUND Invitrogen is a De laware cor poration, with its principal place of business in Carlsbad, California and manufa cturing and distribution facilities located in F rederick, Mar yland.